The stock of Healthpeak Properties Inc (DOC) has seen a 5.60% increase in the past week, with a 1.20% gain in the past month, and a -5.33% decrease in the past quarter. The volatility ratio for the week is 1.71%, and the volatility levels for the past 30 days are at 2.06% for DOC. The simple moving average for the last 20 days is 4.40% for DOC stock, with a simple moving average of 1.59% for the last 200 days.
Is It Worth Investing in Healthpeak Properties Inc (NYSE: DOC) Right Now?
Healthpeak Properties Inc (NYSE: DOC) has a price-to-earnings ratio that is above its average at 44.94x. The stock has a 36-month beta value of 1.13. Opinions on the stock are mixed, with 9 analysts rating it as a “buy,” 6 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for DOC is 697.30M, and at present, short sellers hold a 1.59% of that float. On January 22, 2025, the average trading volume of DOC was 4.99M shares.
DOC) stock’s latest price update
Healthpeak Properties Inc (NYSE: DOC) has seen a rise in its stock price by 1.64 in relation to its previous close of 20.78. However, the company has experienced a 5.60% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-01-15 that DENVER–(BUSINESS WIRE)–Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today the tax treatment of its 2024 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid to shareholders during the calendar year ended December 31, 2024: Common Stock (CUSIP # 42250P103) Ordinary Dividends Capital Gains Record Date Payment Date Dis.
Analysts’ Opinion of DOC
Many brokerage firms have already submitted their reports for DOC stocks, with Morgan Stanley repeating the rating for DOC by listing it as a “Overweight.” The predicted price for DOC in the upcoming period, according to Morgan Stanley is $25 based on the research report published on January 15, 2025 of the current year 2025.
Deutsche Bank, on the other hand, stated in their research note that they expect to see DOC reach a price target of $28, previously predicting the price at $20. The rating they have provided for DOC stocks is “Buy” according to the report published on October 21st, 2024.
DOC Trading at 0.51% from the 50-Day Moving Average
After a stumble in the market that brought DOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.20% of loss for the given period.
Volatility was left at 2.06%, however, over the last 30 days, the volatility rate increased by 1.71%, as shares surge +5.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.18% lower at present.
During the last 5 trading sessions, DOC rose by +5.60%, which changed the moving average for the period of 200-days by +14.91% in comparison to the 20-day moving average, which settled at $20.23. In addition, Healthpeak Properties Inc saw 4.19% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for DOC
Current profitability levels for the company are sitting at:
- 0.2 for the present operating margin
- 0.39 for the gross margin
The net margin for Healthpeak Properties Inc stands at 0.11. The total capital return value is set at 0.02. Equity return is now at value 4.11, with 1.74 for asset returns.
Based on Healthpeak Properties Inc (DOC), the company’s capital structure generated 0.51 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 1.04. The interest coverage ratio of the stock is 1.63.
Currently, EBITDA for the company is 1.19 billion with net debt to EBITDA at 5.87. When we switch over and look at the enterprise to sales, we see a ratio of 10.98. The receivables turnover for the company is 2.88for trailing twelve months and the total asset turnover is 0.11.
Conclusion
To sum up, Healthpeak Properties Inc (DOC) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
